Both in Pharmaceuticals
MoonLake Immunotherapeutics vs Latigo Biotherapeutics
Over the past year MLTX returned −7.6% and LTGO returned −36.6%; their daily moves had a correlation of 0.48.
MLTX −7.6% LTGO −36.6%Growth of $1, one year, split-adjusted
| Metric | MLTX | LTGO |
|---|---|---|
| Price | $11.56 | $14.04 |
| Market cap | $983.8M | $930.8M |
| Today | −1.20% | −3.64% |
| 1 month | +5.6% | −13.7% |
| 6 months | −34.7% | — |
| Year to date | −12.3% | — |
| 1 year | +13.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $437.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 57.0% | — |
| Short % of float | 14.3% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).